Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients

被引:0
|
作者
Deanna M Green
Kathryn E McDougal
Scott M Blackman
Patrick R Sosnay
Lindsay B Henderson
Kathleen M Naughton
J Michael Collaco
Garry R Cutting
机构
[1] Johns Hopkins University School of Medicine,Division of Pediatric Respiratory Sciences
[2] Johns Hopkins University,Department of Epidemiology, Bloomberg School of Public Health
[3] Johns Hopkins University School of Medicine,McKusick
[4] Johns Hopkins University School of Medicine,Nathans Institute of Genetic Medicine
来源
关键词
Cystic Fibrosis; Lung Function; Genetic Modifier; Cystic Fibrosis Patient; Methicillin Resistant Staphylococcus Aureus;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
    Pranke, Iwona M.
    Hatton, Aurelie
    Simonin, Juliette
    Jais, Jean Philippe
    Le Pimpec-Barthes, Francoise
    Carsin, Ania
    Bonnette, Pierre
    Fayon, Michael
    Stremler-Le Bel, Nathalie
    Grenet, Dominique
    Thumerel, Matthieu
    Mazenq, Julie
    Urbach, Valerie
    Mesbahi, Myriam
    Girodon-Boulandet, Emanuelle
    Hinzpeter, Alexandre
    Edelman, Aleksander
    Sermet-Gaudelus, Isabelle
    SCIENTIFIC REPORTS, 2017, 7
  • [22] HIGH RISK CFTR MUTATIONS AND FEMALE SEX ARE PREDICTORS OF MORE RAPID LUNG FUNCTION DECLINE IN CHILDREN WITH CF
    Ren, C. L.
    Emerson, J.
    Schechter, M. S.
    Gibson, R. L.
    Morgan, W. J.
    Rosenfeld, M.
    PEDIATRIC PULMONOLOGY, 2013, 48 : 373 - 373
  • [23] Correction of CFTR function in nasal epithelial cells from cystic fibrosis patients predicts improvement of respiratory function by CFTR modulators
    Iwona M. Pranke
    Aurélie Hatton
    Juliette Simonin
    Jean Philippe Jais
    Françoise Le Pimpec-Barthes
    Ania Carsin
    Pierre Bonnette
    Michael Fayon
    Nathalie Stremler-Le Bel
    Dominique Grenet
    Matthieu Thumerel
    Julie Mazenq
    Valerie Urbach
    Myriam Mesbahi
    Emanuelle Girodon-Boulandet
    Alexandre Hinzpeter
    Aleksander Edelman
    Isabelle Sermet-Gaudelus
    Scientific Reports, 7
  • [24] Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations
    Harutyunyan, Misak
    Huang, Yunjie
    Mun, Kyu-Shik
    Yang, Fanmuyi
    Arora, Kavisha
    Naren, Anjaparavanda P.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2018, 314 (04) : 1529 - 1543
  • [25] CFTR gene analysis in Latin American CF patients:: Heterogeneous origin and distribution of mutations across the continent
    Perez, Martin M.
    Luna, Maria Cecilia
    Pivetta, Omar H.
    Keyeux, Genoveva
    JOURNAL OF CYSTIC FIBROSIS, 2007, 6 (03) : 194 - 208
  • [27] UTILIZATION OF AN "N-OF-1" STUDY DESIGN TO TEST THE EFFECT OF IVACAFTOR IN CF PATIENTS WITH RESIDUAL CFTR FUNCTION AND FEV1 ≥40% OF PREDICTED
    Nick, Jerry A.
    Rodman, David
    St Clair, Connie
    Jones, Marion C.
    Li, Haihong
    Higgins, Mark
    PEDIATRIC PULMONOLOGY, 2014, 49 : 188 - 189
  • [28] Mutations near the predicted catalytic site of NBD1 affect CFTR CF channel function surprisingly little
    Vergani, P
    Csanady, L
    Basso, C
    Sanchez, R
    Naim, AC
    Gadsby, DC
    BIOPHYSICAL JOURNAL, 2000, 78 (01) : 264A - 264A
  • [29] Analysis of respiratory function in patients with multiple sclerosis
    Del Corral Nunez-Flores, Tamara
    Aguilar Zafra, Sandra
    De Gabriel Hierro, Almudena
    Montero Gonzalez, Noelia
    De Uralde Villanueva, Ibai Lopez
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [30] THE SPECTRUM OF CFTR MUTATIONS IN A LARGE SAMPLE OF CF PATIENTS IN FRANCE - DETERMINATION BY DENATURING GRADIENT GEL-ELECTROPHORESIS
    FANEN, P
    MARTIN, J
    GHANEM, N
    BESMOND, C
    ZOBER, Y
    VIDAUD, M
    GOOSSENS, M
    AMERICAN JOURNAL OF HUMAN GENETICS, 1991, 49 (04) : 97 - 97